Company Profile
Oxford Nanopore Technologies provides the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.
The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version of hardware, software, and chemistry
PromethION products, such as PromethION 2, PromethION 24, and PromethION 48. The company has a collaboration with Cepheid to develop and commercialize automated infectious disease sequencing solutions.
It operates in the region of Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. Incorporated in 2005 and headquartered in Oxford, the United Kingdom, Oxford Nanopore Technologies was formerly known as Oxford NanoLabs Limited before rebranding in May 2008.